EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis

被引：0
|
作者：
Shaofei Chen
Jiarui Pu
Jie Bai
Yuping Yin
Ke Wu
Jiliang Wang
Xiaoming Shuai
Jinbo Gao
Kaixiong Tao
Guobin Wang
Hang Li
机构：
[1] Union Hospital,Department of Gastrointestinal Surgery
[2] Tongji Medical College,Department of Pediatric Surgery
[3] Huazhong University of Science and Technology,undefined
[4] Union Hospital,undefined
[5] Tongji Medical College,undefined
[6] Huazhong University of Science and Technology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 37卷
关键词：
Galectin-9; EZH2; Hepatocellular carcinoma; Proliferation; Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
    Chen, Shaofei
    Pu, Jiarui
    Bai, Jie
    Yin, Yuping
    Wu, Ke
    Wang, Jiliang
    Shuai, Xiaoming
    Gao, Jinbo
    Tao, Kaixiong
    Wang, Guobin
    Li, Hang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [2] HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis
    Shi, Yang
    Yang, Xiaohua
    Xue, Xiaofeng
    Sun, Ding
    Cai, Peng
    Song, Qingwei
    Zhang, Bin
    Qin, Lei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 506 (01) : 189 - 193
  • [3] HOMER3 promotes liver hepatocellular carcinoma cancer progression by -upregulating EZH2 and mediating miR-361/GPNMB axis
    Chen, Lixia
    Shan, Xiangxiang
    Wan, Xinqiang
    Zha, Wenzhang
    Fan, Rengen
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [4] EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma
    Lu, Juan
    Zhao, Fei-Peng
    Peng, Zengliu
    Zhang, Meng-Wen
    Lin, Shao-Xiong
    Liang, Bi-Jun
    Zhang, Bao
    Liu, Xiong
    Wang, Lu
    Li, Gang
    Tian, Wen-Dong
    Peng, Ying
    He, Ming-Liang
    Li, Xiang-Ping
    ONCOTARGET, 2014, 5 (22) : 11319 - 11332
  • [5] miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males
    Jiang, Runqiu
    Deng, Lei
    Zhao, Liang
    Li, Xiangcheng
    Zhang, Feng
    Xia, Yongxiang
    Gao, Yun
    Wang, Xuehao
    Sun, Beicheng
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5593 - 5603
  • [6] The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
    Wu, Shi-yi
    Xie, Zhao-yu
    Yan, Lu-yu
    Liu, Xiao-fang
    Zhang, Yue
    Wang, Da-an
    Dong, Jie
    Sun, Hong-tao
    BMC IMMUNOLOGY, 2022, 23 (01)
  • [7] The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
    Shi-yi Wu
    Zhao-yu Xie
    Lu-yu Yan
    Xiao-fang Liu
    Yue Zhang
    Da-an Wang
    Jie Dong
    Hong-tao Sun
    BMC Immunology, 23
  • [8] LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2
    Guo, Yongjian
    Bai, Mingjun
    Lin, Liteng
    Huang, Jingjun
    An, Yongcheng
    Liang, Licong
    Liu, Yaohong
    Huang, Wensou
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [9] The EZH2/MCM Complex/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence
    Shen, Ziyi
    Wang, Yuanhui
    Gao, Jie
    Gu, Wei
    Ren, Ziyi
    Xu, Luanqi
    Qian, Rui
    Miao, Qinyi
    Hu, Xiaomeng
    Wu, Yan
    Liu, Wei
    Cai, Yi
    Wan, Chunpeng
    Zhu, Yansong
    Sun, Lei
    Yan, Tingdong
    MECHANISMS OF AGEING AND DEVELOPMENT, 2025, 224
  • [10] EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Bohan Wang
    Yachong Liu
    Zhibin Liao
    Haofeng Wu
    Bixiang Zhang
    Lei Zhang
    Experimental Hematology & Oncology, 12
12345